DermaSensor Inc.: Funding, Investors & Team (Sep 2026)
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of Americans report never having been checked for skin cancer. The DermaSensor device is an affordable, handheld tool that uses machine learning and spectroscopy to objectively evaluate skin lesions for potential cancer in seconds.
DermaSensor Inc. has raised $15.5M across 2 funding rounds on record, the most recent a Series B of $4.0M announced in Sep 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
DermaSensor Inc. Company Profile and Key Stats
Latest funding round on record: Sep 2026.
DermaSensor Inc. Funding Rounds
DermaSensor Inc. raised $11.5M in an undisclosed round announced in Jun 2020.
6.3 years later, a Series B of $4.0M was announced in Sep 2026.
DermaSensor Inc. Investors
14 investors are recorded in total; the 5 named above are those the record identifies.
DermaSensor Inc. Founders and Leadership Team
Contact details for the DermaSensor Inc. team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →DermaSensor Inc. Funding Compared to Other Biotechnology Startups
DermaSensor Inc.'s latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DermaSensor Inc. in Biotechnology and Miami
Companies Similar to DermaSensor Inc.
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
DermaSensor Inc. Funding FAQs
What does DermaSensor Inc. do?
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of Americans report never having been checked for skin cancer. The DermaSensor device is an affordable, handheld tool that uses machine learning and spectroscopy to objectively evaluate skin lesions for potential cancer in seconds.
How much funding has DermaSensor Inc. raised?
DermaSensor Inc. has raised $15.5M across 2 rounds on record. The most recent is a Series B of $4.0M announced in Sep 2026.
When did DermaSensor Inc. last raise funding?
DermaSensor Inc.'s most recent funding round on record is a Series B of $4.0M, announced in Sep 2026.
Who has invested in DermaSensor Inc.?
Investors on record for DermaSensor Inc. include Harmonix Fund, SternAegis, Pier 70 Ventures, Miami Angels, Kern Venture Group. FundedIQ records 14 investors in total.
Who is the CEO of DermaSensor Inc.?
Cody Simmons is listed as CEO at DermaSensor Inc..
Where is DermaSensor Inc. headquartered?
DermaSensor Inc. is based in Miami, Florida, United States.
How many employees does DermaSensor Inc. have?
DermaSensor Inc. is in the 11-50 employee band.
When was DermaSensor Inc. founded?
DermaSensor Inc. was founded in 2009.
How does DermaSensor Inc.'s funding compare to other Biotechnology startups?
DermaSensor Inc.'s latest round of $4.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's DermaSensor Inc. Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DermaSensor Inc. is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.